Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
Brian J. Sworder(City Of Hope National Medical Center), Ash A. Alizadeh(California Institute for Regenerative Medicine)
Cited by 130
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770